Accuracy of fetal growth indicators as surrogate measures of steroid hormone levels during pregnancy.

This study evaluates the use of fetal growth characteristics as surrogate measures for steroid hormone exposures during pregnancy. The validity of using birth weight, birth length, ponderal index, and placental weight as indicators of pregnancy hormone exposures was assessed using third-trimester serum samples from 568 pregnant women who participated in the Child Health and Development Studies, Berkeley, California (1959-1966). The magnitude of the associations between birth characteristics and hormone concentrations was assessed using geometric means, Pearson's correlations, and linear and logistic regression. Accuracy was evaluated using sensitivity, specificity, and receiver operating characteristic curve analyses. The strongest and most consistent association observed was between birth weight and estriol levels. Despite a positive correlation (r = 0.32) and strong associations with high estriol levels (odds ratio for highest compared with lowest birth weight quartile = 6.63, 95% confidence interval: 3.20, 12.5), the predictive performance of birth weight as a proxy for estriol levels was poor (area under the receiver operating characteristic curve = 0.66, 95% confidence interval: 0.61, 0.71). Likewise, all fetal growth measures revealed little discriminatory ability as indicators of estriol, estrone, estradiol, or progesterone levels. Thus, observed associations with these surrogate measures may not be a reflection of pregnancy hormone exposure and should be interpreted with caution.

[1]  D. Trichopoulos Hypothesis: does breast cancer originate in utero? , 1990, The Lancet.

[2]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[3]  M. Pike,et al.  Higher maternal levels of free estradiol in first compared to second pregnancy: early gestational differences. , 1986, Journal of the National Cancer Institute.

[4]  Mats Lambe,et al.  Maternal risk of breast cancer following multiple births: a nationwide study in Sweden , 1996, Cancer Causes & Control.

[5]  H. Adami,et al.  Evidence of prenatal influences on breast cancer risk , 1992, The Lancet.

[6]  R. Christianson,et al.  The California Child Health and Development Studies of the School of Public Health, University of California at Berkeley. , 1988, Paediatric and perinatal epidemiology.

[7]  D. Trichopoulos,et al.  Baldness and other correlates of sex hormones in relation to testicular cancer , 1997, International journal of cancer.

[8]  W. Cleveland,et al.  Effects of fetal sex and weight and placental weight on maternal serum progesterone and chorionic gonadotropin concentrations. , 1975, American journal of obstetrics and gynecology.

[9]  E. Thurfjell,et al.  Perinatal characteristics and adult mammographic patterns , 1995, International journal of cancer.

[10]  H. Adami,et al.  Breast cancer risk in mothers of multiple births , 1993, International journal of cancer.

[11]  J. Stanford,et al.  Perinatal Factors and Risk of Breast Cancer , 1996, Epidemiology.

[12]  E. Johansson,et al.  Plasma Levels of Nonconjugated Oestrone, Oestradiol‐17β and Oestriol During Uncomplicated Pregnancy , 1974, Acta obstetricia et gynecologica Scandinavica. Supplement.

[13]  Leon Speroff,et al.  Clinical gynecologic endocrinology and infertility , 1983 .

[14]  M. Pike,et al.  Risk factors for cancer of the testis in young men , 1979, International journal of cancer.

[15]  B. Eskenazi,et al.  Black-white differences in serum cotinine levels among pregnant women and subsequent effects on infant birthweight. , 1994, American journal of public health.

[16]  L. Berstein,et al.  Newborn macrosomy and cancer. , 1988, Advances in cancer research.

[17]  W. Cleveland Robust Locally Weighted Regression and Smoothing Scatterplots , 1979 .

[18]  B. Runnebaum,et al.  Estrogen screening in evaluation of fetal outcome and infant’s development , 1986, Journal of perinatal medicine.

[19]  D T Janerich,et al.  Hypertension, pregnancy, and risk of breast cancer. , 1989, Journal of the National Cancer Institute.

[20]  H. Hoffman,et al.  Prediction of fetal growth based on maternal serum concentrations of human chorionic gonadotropin, human placental lactogen and estriol. , 1997, Acta obstetricia et gynecologica Scandinavica. Supplement.

[21]  M. Mahoney,et al.  The relation between multiple births and maternal risk of breast cancer. , 1992, American journal of epidemiology.

[22]  M. Longnecker,et al.  Multiple births and risk of breast cancer , 1995, International journal of cancer.

[23]  J. A. Calvin,et al.  Levels of maternal serum alpha-fetoprotein (AFP) in pregnant women and subsequent breast cancer risk. , 1998, American journal of epidemiology.

[24]  B. Hulka,et al.  Steroid hormones and risk of breast cancer , 1994, Cancer.

[25]  M. Melbye,et al.  Maternal risk of breast cancer and birth characteristics of offspring by time since birth. , 1999, Epidemiology.

[26]  G. Masson,et al.  Variability of total plasma oestriol in late human pregnancy. , 1972, The Journal of endocrinology.

[27]  J A Swets,et al.  Measuring the accuracy of diagnostic systems. , 1988, Science.

[28]  L D Marrett,et al.  Pre‐natal and peri‐natal exposures and risk of testicular germ‐cell cancer , 2000, International journal of cancer.

[29]  H. Adami,et al.  Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer , 1999, British Journal of Cancer.

[30]  G. Wyshak,et al.  Cancer in mothers of dizygotic twins. , 1983, Journal of the National Cancer Institute.

[31]  C R Weinberg,et al.  Randomized recruitment in case-control studies. , 1991, American journal of epidemiology.

[32]  M. Pike,et al.  Cigarette smoking in pregnancy results in marked decrease in maternal hCG and oestradiol levels , 1989, British journal of obstetrics and gynaecology.

[33]  F. Walther,et al.  The Ponderal Index as a measure of the nutritional Status at birth and its relation to some aspects of neonatal morbidity , 1982, Journal of perinatal medicine.

[34]  E. C. Amoroso Endocrinology of pregnancy. , 1955, British medical bulletin.

[35]  P. Siiteri,et al.  Placental Estrogen Biosynthesis During Human Pregnancy1 , 1966 .

[36]  K. Katsouyanni,et al.  Tobacco smoking, pregnancy estrogens, and birth weight. , 1990, Epidemiology.

[37]  H. Ruder,et al.  Estrone sulfate, estrone, estradiol and estriol plasma levels in human pregnancy. , 1972, The Journal of clinical endocrinology and metabolism.

[38]  M. Pike,et al.  Estrogen exposure during gestation and risk of testicular cancer. , 1983, Journal of the National Cancer Institute.

[39]  L. Kuller,et al.  Usefulness of sex steroid hormone levels in predicting coronary artery disease in men. , 1987, The American journal of cardiology.

[40]  H. Hoffman,et al.  Maternal serum concentrations of human placental lactogen, estradiol and pregnancy specific beta 1-glycoprotein and fetal growth retardation. , 1997, Acta obstetricia et gynecologica Scandinavica. Supplement.

[41]  B. Henderson,et al.  Hormonal factors and risk of ovarian germ cell cancer in young women. , 1988, British Journal of Cancer.

[42]  P. Siiteri,et al.  Estrogens and Breast Cancer , 1986, Clinical obstetrics and gynecology.

[43]  Polednak Ap,et al.  Characteristics of first pregnancy in relation to early breast cancer. A case-control study. , 1983 .

[44]  W. Thompson,et al.  Multiple births and maternal risk of breast cancer. , 1989, American journal of epidemiology.

[45]  H. Adami,et al.  Intrauterine environment and breast cancer risk in women: a population-based study. , 1997, Journal of the National Cancer Institute.

[46]  I. McFadyen,et al.  High oestrogen excretion in pregnancy , 1982, British journal of obstetrics and gynaecology.

[47]  P. Siiteri,et al.  The utilization of circulating dehydroisoandrosterone sulfate for estrogen synthesis during human pregnancy , 1963 .

[48]  L. Bernstein,et al.  Breastfeeding history, pregnancy experience and risk of breast cancer. , 1997, British Journal of Cancer.

[49]  A. Klopper,et al.  Variability of Fetoplacental Steroids in Maternal Plasma in Late Pregnancy , 1974, Obstetrics and gynecology.

[50]  R. Hoover,et al.  Pregnancy Characteristics and Maternal Risk of Breast Cancer , 1998, Epidemiology.

[51]  A. Klopper,et al.  THE VARIABILITY OF PLASMA OESTRADIOL CONCENTRATION IN LATE PREGNANCY , 1974, The Journal of obstetrics and gynaecology of the British Commonwealth.

[52]  M. Pike,et al.  Cigarette smoking and steroid hormones in women , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[53]  S. Cnattingius,et al.  Maternal pregnancy estriol levels in relation to anamnestic and fetal anthropometric data. , 2000, Epidemiology.

[54]  B. Runnebaum,et al.  Weight percentile at birth. II. Prediction by endocrinological and sonographic measurements. , 1987, European journal of obstetrics, gynecology, and reproductive biology.

[55]  Conversion of H3-Dehydroisoandrosterone (3β-Hydroxy-Δ5-androsten-17-one) Sulfate to H3-Estrogens in Normal Pregnant Women , 1963 .

[56]  J. Cerhan,et al.  Twinship and risk of postmenopausal breast cancer. , 2000, Journal of the National Cancer Institute.

[57]  J. Robins,et al.  Birthweight as a risk factor for breast cancer , 1996, The Lancet.

[58]  S. C. Freed ESTROGENS AND ANDROGENS , 1943 .

[59]  K. Katsouyanni,et al.  Maternal age, parity, and pregnancy estrogens , 1990, Cancer Causes & Control.

[60]  C. Hobel,et al.  Plasma estrone, estradiol, estriol, progesterone, and 17-hydroxyprogesterone in human pregnancy. I. Normal pregnancy. , 1972, American journal of obstetrics and gynecology.

[61]  Ivar Heuch,et al.  Multiple births, sex of children and subsequent breast‐cancer risk for the mothers: A prospective study in Norway , 2006, International journal of cancer.

[62]  F. Berrino,et al.  Validity for epidemiological studies of long-term cryoconservation of steroid and protein hormones in serum and plasma. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.